Epigenetic architecture remodeling and subsequent deregulation of EZH2 and Wnt pathways, as well as PI3kinase/AKT and IGFR1 signaling cascades, unravel CLL-derived RS underlying mechanisms potentially responsible for chemotherapy resistance. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.